Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 19;6(1):e1000.
doi: 10.1097/CCE.0000000000001000. eCollection 2024 Jan.

Corticosteroids in Sepsis and Septic Shock: A Systematic Review, Pairwise, and Dose-Response Meta-Analysis

Affiliations

Corticosteroids in Sepsis and Septic Shock: A Systematic Review, Pairwise, and Dose-Response Meta-Analysis

Tyler Pitre et al. Crit Care Explor. .

Abstract

Objectives: To perform a systematic review and meta-analysis to assess the efficacy and safety of corticosteroids in patients with sepsis.

Data sources: We searched PubMed, Embase, and the Cochrane Library, up to January 10, 2023.

Study selection: We included randomized controlled trials (RCTs) comparing corticosteroids with placebo or standard care with sepsis.

Data extraction: The critical outcomes of interest included mortality, shock reversal, length of stay in the ICU, and adverse events.

Data analysis: We performed both a pairwise and dose-response meta-analysis to evaluate the effect of different corticosteroid doses on outcomes. We used Grading of Recommendations Assessment, Development and Evaluation to assess certainty in pooled estimates.

Data synthesis: We included 45 RCTs involving 9563 patients. Corticosteroids probably reduce short-term mortality (risk ratio [RR], 0.93; 95% CI, 0.88-0.99; moderate certainty) and increase shock reversal at 7 days (RR, 1.24; 95% CI, 1.11-1.38; high certainty). Corticosteroids may have no important effect on duration of ICU stay (mean difference, -0.6 fewer days; 95% CI, 1.48 fewer to 0.27 more; low certainty); however, probably increase the risk of hyperglycemia (RR, 1.13; 95% CI, 1.08-1.18; moderate certainty) and hypernatremia (RR, 1.64; 95% CI, 1.32-2.03; moderate certainty) and may increase the risk of neuromuscular weakness (RR, 1.21; 95% CI, 1.01-1.45; low certainty). The dose-response analysis showed a reduction in mortality with corticosteroids with optimal dosing of approximately 260 mg/d of hydrocortisone (RR, 0.90; 95% CI, 0.83-0.98) or equivalent.

Conclusions: We found that corticosteroids may reduce mortality and increase shock reversal but they may also increase the risk of hyperglycemia, hypernatremia, and neuromuscular weakness. The dose-response analysis indicates optimal dosing is around 260 mg/d of hydrocortisone or equivalent.

Keywords: corticosteroids; critical illness; meta-analysis; sepsis; septic shock.

PubMed Disclaimer

Conflict of interest statement

The authors have disclosed that they do not have any potential conflicts of interest.

Figures

Figure 1.
Figure 1.
Forest plot for short-term mortality. ML = Maximum likelihood.
Figure 2.
Figure 2.
Dose-response analysis for short-term mortality, with the representing the effect size and the ribbons representing the 95% CIs.

References

    1. Salluh JI, Póvoa P: Corticosteroids in severe sepsis and septic shock: A concise review. Shock 2017; 47(1S Suppl 1):47–51 - PubMed
    1. Vandewalle J, Libert C: Glucocorticoids in sepsis: To be or not to be. Front Immunol 2020; 11:1318. - PMC - PubMed
    1. Rochwerg B, Oczkowski SJ, Siemieniuk RAC, et al. : Corticosteroids in sepsis: An updated systematic review and meta-analysis. Crit Care Med 2018; 46:1411–1420 - PubMed
    1. Annane D, Bellissant E, Bollaert PE, et al. : Corticosteroids for treating sepsis in children and adults. Cochrane Database Syst Rev 2019; 12:CD002243. - PMC - PubMed
    1. Page MJ, McKenzie JE, Bossuyt PM, et al. : The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021; 372:n71. - PMC - PubMed